From: "Wise, Alicia (ELS-OXF)" <[log in to unmask]> Date: Fri, 8 Nov 2013 11:16:41 +0000 Hi David, Yes, I'm also on a steep learning curve here. Each year the titles in the Freedom Collection are newly defined, with joiners and leavers. There are always some free titles within it - for example discontinued titles or forthcoming titles for which there is not yet a price (or a really clear business model, as in this case) in December when the Freedom Collection is defined. The free titles do not define the value of the Freedom Collection and there is no Freedom Collection revenue allocated to these journals. Customers can request an overview of the journals and their value in the Freedom Collection and validate which journals are free. While here, I should also acknowledge the various messages (all kind and private; most charming and funny) since my original post, and would hereby like to apologize to any and all I may have offended/alarmed by using complementary rather than complimentary! With very kind wishes, Alicia Dr Alicia Wise Director of Universal Access Elsevier I The Boulevard I Langford Lane I Kidlington I Oxford I OX5 1GB M: +44 (0) 7823 536 826 I E: [log in to unmask] Twitter: @wisealic -----Original Message-----From: David Prosser <[log in to unmask]> Date: Thu, 31 Oct 2013 08:28:45 +0000 Hi Alicia Thanks for this - very helpful. I must admit that in my ignorance I didn't realise that some of the journals in the Freedom Collection were complementary - a sort of "buy 2000, get 50 free"? Is there a list of these titles - I was probably looking in the wrong place, but I couldn't find one. All I found was the general Freedom Collection list (http://info.sciencedirect.com/techsupport/journals/freedomcoll.htm) and it's not mentioned there. Thanks David On 30 Oct 2013, at 23:40, LIBLICENSE wrote: From: "Wise, Alicia (ELS-OXF)" <[log in to unmask]> Date: Wed, 30 Oct 2013 17:17:58 +0000 Hi David and Joe, I'm writing to respond to the thread you started about Drug Invention Today. As a result of the Bohannon article we have been investigating this title, and have uncovered a number of issues. There is a formal process underway at present to address these. We are indeed committed to the integrity and quality of the scientific record, and hold this as one of Elsevier's fundamental principles. In our contracts with organizations for whom we host content, as in this case, we clearly lay out quality assurance expectations. In this case there was poor - very poor - compliance. We are reviewing our compliance monitoring and tracking procedures. The title was included in the Freedom Collection as part of the complementary title list, had no assigned cost, and subsequently no "big deal' revenue. With kind wishes, Alicia Dr Alicia Wise Director of Access and Policy Elsevier [log in to unmask] @wisealic -----Original Message----- From: David Prosser <[log in to unmask]> Date: Mon, 28 Oct 2013 15:07:48 +0000 I agree, it's not at all an easy call. intuitively, I'd say that it depends on the level of service. I don't think that anybody would suggest that a typesetter, to take an extreme example, has any responsibility for the editorial content. I would suggest that neither does a hosting service such as HighWire. But the publisher? What if a publisher says something along the lines of: "Access peer reviewed full-text articles...Looking for trusted content?" (http://info.sciencedirect.com/sciencedirect?utm_source=sciencedirect&utm_medium=link&utm_campaign=aboutsd) as Elsevier does for ScienceDirect (and I'm sure if I checked all the publishers would say something similar about their own platforms)? Does the customer not have some expectation that what they are paying for is actually peer reviewed? Obviously, we can balk at service providers making the editorial decisions, but surely it is not unreasonable to expect that the providers can at least verify the claims they are making to customers. David